IL-6, IL-8, and IL-10 are associated with hyperferritinemia in rapidly progressive interstitial lung disease with polymyositis/dermatomyositis

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Kawasumi, Hidenaga ^a   Gono, Takahisa ^a   Kawaguchi, Yasushi ^a   Kaneko, Hirotaka ^a   Katsumata, Yasuhiro ^a   Hanaoka, Masanori ^a   Kataoka, Sayuri ^a   Yamanaka, Hisashi ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; FERRITIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; INTERLEUKIN DERIVATIVE;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DERMATOMYOSITIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; HYPERFERRITINEMIA; INTERSTITIAL LUNG DISEASE; MALE; POLYMYOSITIS; RETROSPECTIVE STUDY; THORAX RADIOGRAPHY; VISUAL ANALOG SCALE; BLOOD; COMPLICATION; IRON METABOLISM DISORDERS; LUNG DISEASES, INTERSTITIAL; MIDDLE AGED;

ADULT; DERMATOMYOSITIS; FEMALE; FERRITINS; HUMANS; INTERLEUKINS; IRON METABOLISM DISORDERS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84899537771     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/815245     Document Type: Article

References (19)

1. Mimori T., Nakashima R., Hosono Y., Interstitial lung disease in myositis: clinical subsets, biomarkers, and treatment. Current Rheumatology Reports 2012 14 3 264 274 2-s2.0-84857282735 10.1007/s11926-012-0246-6
2. Dankó K., Ponyi A., Constantin T., Borgulya G., Szegedi G., Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases. Medicine 2004 83 1 35 42 2-s2.0-1642494599 10.1097/01.md.0000109755.65914.5e
3. Marie I., Morbidity and mortality in adult polymyositis and dermatomyositis. Current Rheumatology Reports 2012 14 275 285 2-s2.0-84857981751 10.1007/s11926-012-0249-3
4. Nakashima R., Imura Y., Kobayashi S., Yukawa N., Yoshifuji H., Nojima T., Kawabata D., Ohmura K., Usui T., Fujii T., Okawa K., Mimori T., The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody. Rheumatology 2009 49 3 433 440 2-s2.0-77950534717 10.1093/rheumatology/kep375
5. Gono T., Kawaguchi Y., Satoh T., Kuwana M., Katsumata Y., Takagi K., Masuda I., Tochimoto A., Baba S., Okamoto Y., Ota Y., Yamanaka H., Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis. Rheumatology 2010 49 9 1713 1719 2-s2.0-77955728626 10.1093/rheumatology/keq149
6. Hamaguchi Y., Kuwana M., Hoshino K., Hasegawa M., Kaji K., Matsushita T., Komura K., Nakamura M., Kodera M., Suga N., Higashi A., Ogusu K., Tsutsui K., Furusaki A., Tanabe H., Sasaoka S., Muro Y., Yoshikawa M., Ishiguro N., Ayano M., Muroi E., Fujikawa K., Umeda Y., Kawase M., Mabuchi E., Asano Y., Sodemoto K., Seishima M., Yamada H., Sato S., Takehara K., Fujimoto M., Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study. Archives of Dermatology 2011 147 4 391 398 2-s2.0-79953837289 10.1001/archdermatol.2011.52
7. Hall J. C., Casciola-Rosen L., Samedy L. A., Werner J., Owoyemi K., Danoff S. K., Christopher-Stine L., Anti-melanoma differentiation-associated protein 5-associated dermatomyositis: expanding the clinical spectrum. Arthritis Care & Research 2013 65 1307 1315 10.1002/acr.21992
8. Gono T., Kawaguchi Y., Hara M., Masuda I., Katsumata Y., Shinozaki M., Ota Y., Ozeki E., Yamanaka H., Increased ferritin predicts development and severity of acute interstitial lung disease as a complication of dermatomyositis. Rheumatology 2010 49 7 1354 1360 2-s2.0-77954196479 10.1093/rheumatology/keq073
9. Gono T., Miyake K., Kawaguchi Y., Kaneko H., Shinozaki M., Yamanaka H., Hyperferritinaemia and macrophage activation in a patient with interstitial lung disease with clinically amyopathic DM. Rheumatology 2012 51 1336 1338 10.1093/rheumatology/kes012
10. Bohan A., Peter J., Polymyositis and dermatomyositis (first of two parts). New England Journal of Medicine 1975 292 7 344 347 2-s2.0-0016850495
11. Sontheimer R., Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis siné myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? Journal of the American Academy of Dermatology 2002 46 4 626 636
12. Sato S., Hoshino K., Satoh T., Fujita T., Kawakami Y., Fujita T., Kuwana M., RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: association with rapidly progressive interstitial lung disease. Arthritis and Rheumatism 2009 60 7 2193 2200 2-s2.0-67650084778 10.1002/art.24621
13. Miller F. W., New approaches to the assessment and treatment of the idiopathic inflammatory myopathies. Annals of the Rheumatic Diseases 2012 71 supplement 2 i82 i85 2-s2.0-84859506374 10.1136/annrheumdis-2011-200587
14. Reed A. M., Peterson E., Bilgic H., Ytterberg S. R., Amin S., Hein M. S., Crowson C. S., Ernste F., Gillespie E. B., Changes in novel biomarkers of disease activity in juvenile and adult dermatomyositis are sensitive biomarkers of disease course. Arthritis & Rheumatism 2012 64 12 4078 4086 10.1002/art.34659
15. Wang W., Grier D. D., Woo J., Ward M., Sui G., Torti S. V., Torti F. M., Beaty M. W., Ferritin H is a novel marker of early erythroid precursors and macrophages. Histopathology 2013 62 6 931 940 10.1111/his.12101
16. Koorts A. M., Levay P. F., Becker P. J., Viljoen M., Pro- and anti-inflammatory cytokines during immune stimulation: modulation of iron status and red blood cell profile. Mediators of Inflammation 2011 2011 11 2-s2.0-79956304247 10.1155/2011/716301 716301
17. Weiss G., Schett G., Anaemia in inflammatory rheumatic diseases. Nature Reviews Rheumatology 2013 9 205 215
18. Mosser D. M., Edwards J. P., Exploring the full spectrum of macrophage activation. Nature Reviews Immunology 2008 8 12 958 969 2-s2.0-56749174940 10.1038/nri2448
19. A. Agrawal, H. Zhuo, S. Brady et al., "Pathogenetic and predictive value of biomarkers in patients with ALI and lower severity of illness: results from two clinical trials," Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 303, pp. L634-L639, 2012.